Drug record
What four public record sets show for lorazepam. Saved Nov 10, 2026.
| Shortage | On the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.036 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $78.4 million | Details |
| FDA recall records | 21 | Details |
Whether the FDA lists this drug as in short supply.
Reason given: Other
Reason given: Demand increase for the drug
Reason given: Other
Reason given: Other
Reason given: Demand increase for the drug
Reason given: Demand increase for the drug
Reason given: Demand increase for the drug
Reason given: Other
Reason given: Demand increase for the drug
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Lorazepam 0.5 Mg Tablet: pharmacies pay about $0.036 each, or $1.09 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| LORAZEPAM 0.5 MG TABLET | Generic | $0.036 per each | $1.09 | Oct 21, 2026 |
| LORAZEPAM 1 MG TABLET | Generic | $0.037 per each | $1.12 | Oct 21, 2026 |
| LORAZEPAM 2 MG TABLET | Generic | $0.074 per each | $2.21 | Oct 21, 2026 |
| LORAZEPAM 2 MG/ML ORAL CONCENT | Generic | $0.673 per mL | — | Oct 21, 2026 |
| LORAZEPAM 2 MG/ML VIAL | Generic | $2.12 per mL | — | Oct 21, 2026 |
| LORAZEPAM INTENSOL 2 MG/ML | Generic | $0.673 per mL | — | Oct 21, 2026 |
| LOREEV XR 1 MG CAPSULE | Brand | $14.23 per each | $426.84 | Oct 21, 2026 |
| LOREEV XR 1.5 MG CAPSULE | Brand | $14.22 per each | $426.52 | Oct 21, 2026 |
| LOREEV XR 2 MG CAPSULE | Brand | $14.18 per each | $425.36 | Oct 21, 2026 |
| LOREEV XR 3 MG CAPSULE | Brand | $14.22 per each | $426.71 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $78.4 million for the 4 products below. That is up 25% from $62.5 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Lorazepam* Lorazepam | $52.4 million | 1,852,070 | $6.48 | $28.30 | $38.9 million |
| Ativan* Lorazepam | $22.6 million | 1,633 | $3,420.49 | $13,820.21 | $22.4 million |
| Loreev XR Lorazepam | $2.2 million | 1,089 | $453.18 | $2,063.63 | — |
| Lorazepam Intensol Lorazepam | $1.2 million | 28,935 | $29.91 | $39.89 | $1.3 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 21 recall records that name lorazepam in the product description (1 Class I · 19 Class II · 1 Class III). 7 are still marked ongoing.
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Reason: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784.
Reason: Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61
Reason: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-905 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6008-61.
Reason: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-906 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6009-61.
Reason: Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Lorazepam Injection, USP 2 mg/mL vial, 1 mL vials, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs
Reason: CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Lorazepam Oral Concentrate, USP, 2mg per mL, 30 mL bottles, Rx Only, Sterile, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031. ALL NDCs
Reason: CGMP Deviations: Firm went out of business and could no longer continue stability studies.
LORazepam Injection, 2mg / mL Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045, Repackaged by: RemedyRepack Inc., Indiana PA 15701, Source NDC # 17478-0040-01, Remedy NDC 70518-2268-00
Reason: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-25), Rx only, Manufactured by West-Ward, Eatontown, NJ 07724.
Reason: Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.
Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6001-25, Vial NDC# 0641-6001-01
Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01
Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# NDC# 0641-6045-25, Vial NDC# 0641-6045-01
Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for lorazepam. This page is public-record information, not medical advice.